Add BrightSurf on Google Email

Search results for “Pharmacology”

1,000+ results for "Pharmacology"

Novel antidepressant may improve sleep in patients with depression

A novel antidepressant, vortioxetine, has been shown to improve subjective sleep quality and daytime sleepiness in patients with major depressive disorder. The treatment's multimodal effect on serotonin transport and reuptake may have important clinical implications for addressing sleep problems in depression.

SourceWiley·JournalBritish Journal of Clinical Pharmacology·DateOct 17, 2018

Analysis finds HPV vaccine safe

A review of bivalent HPV vaccine data found no new or unexpected safety concerns. The majority of adverse event reports were classified as non-serious and mild.

SourceWiley·JournalBritish Journal of Clinical Pharmacology·DateSep 19, 2018

Unnecessary medicine use in patients with lung cancer at the end of life

A new study analyzed data from two UK and US centers to find that patients with advanced lung cancer often receive multiple medications that may not be beneficial. On average, these patients were prescribed 1.9-2.6 preventative medications at admission and discharge. The authors suggest developing an intervention to reduce inappropriat...

SourceWiley·JournalBritish Journal of Clinical Pharmacology·DateSep 6, 2018

Bee venom may help treat eczema

Researchers found that bee venom and melittin suppress inflammation in atopic dermatitis by regulating T helper cell differentiation. The study suggests bee venom may be an effective treatment for eczema, potentially alleviating inflammatory skin diseases.

SourceWiley·JournalBritish Journal of Pharmacology·DateSep 6, 2018

Can medical marijuana help treat intractable epilepsy?

A review suggests that cannabidiol, a compound in cannabis, may have modest efficacy in treating severe epilepsy, particularly in children. However, more rigorous clinical trials are necessary to fully understand its potential and minimize side effects.

SourceWiley·JournalBritish Journal of Clinical Pharmacology·DateAug 8, 2018

Red-blood-cell 'hitchhikers' offer new way to transport drugs to specific targets

A new drug-delivery technology called RBC-hitchhiking has been found to dramatically increase the concentration of drugs in specific organs, potentially decreasing side effects and improving efficacy. The technology uses red blood cells to transport nano-scale drug carriers, achieving a 40-fold increase in drug uptake in the lungs.

SourceUniversity of Pennsylvania School of Medicine·JournalNature Communications·DateJul 31, 2018

Can doctors identify older patients at risk of medication harm?

A new study found that doctors' predictions of medication-related harm (MRH) in older adults are not reliable. Despite clinical experience and confidence influencing accuracy, predictions were no more accurate than chance. New approaches to identify high-risk individuals are needed to mitigate serious consequences.

SourceWiley·JournalBritish Journal of Clinical Pharmacology·DateJul 2, 2018

Should pharmacists be allowed to write prescriptions?

Allowing pharmacists to write prescriptions is associated with increased access to healthcare services, improved patient outcomes, and enhanced utilisation of their skills. Pharmacists' diagnosis skills were a primary concern among organisational issues.

SourceWiley·JournalBritish Journal of Clinical Pharmacology·DateJun 20, 2018

New journal series provides insights on European medication-related guidelines

A new journal series published in the British Journal of Clinical Pharmacology aims to provide insights into European medication-related guidelines. The series, developed in collaboration with the EMA, offers annotated versions of relevant guidelines and regulatory documents, facilitating discussion among professionals and patients. Ex...

SourceWiley·JournalBritish Journal of Clinical Pharmacology·DateMay 30, 2018

Study points to the futility of urine tests for salbutamol doping

A recent study published in British Journal of Clinical Pharmacology found that large variability in urine concentrations makes it impossible to determine an administered dose from a single untimed urine sample. This highlights the need to reconsider the use of urine tests for detecting salbutamol doping, as many violations will go unn...

SourceWiley·JournalBritish Journal of Clinical Pharmacology·DateMay 3, 2018

Researchers discover connection between circadian rhythm and aggression

A study by researchers at the University of Copenhagen has confirmed a connection between the circadian rhythm and aggression in Alzheimer's patients. The team identified a circuit linking the brain's circadian clock to an aggression centre, suggesting a potential target for pharmacological intervention. This discovery may lead to new ...

Which pain medication is safest for arthritis patients?

A recent study found that celecoxib, an NSAID, had better gastrointestinal safety than ibuprofen or naproxen when co-prescribed with esomeprazole. The medication was associated with infrequent gastrointestinal side effects in arthritis patients, making it a safer option for those taking these medications.

SourceWiley·JournalAlimentary Pharmacology & Therapeutics·DateApr 19, 2018

Articles provide updated guidance to authors submitting to the British Journal of Pharmacology

The British Journal of Pharmacology has published updated guidance for authors on designing experiments, analyzing data, and presenting results. The editorials aim to improve reproducibility and transparency in preclinical research by providing approaches to data presentation and checklists for immunoblotting and immunohistochemistry.

SourceWiley·JournalBritish Journal of Pharmacology·DateApr 16, 2018

Certain pain medications linked to increased heart risks

A recent study published in British Journal of Clinical Pharmacology found a significant link between nonsteroidal anti-inflammatory drugs (NSAIDs) and an increased risk of atrial fibrillation. The research highlights the importance of closely monitoring NSAID use for heart health, particularly among high-risk individuals.

SourceWiley·JournalBritish Journal of Clinical Pharmacology·DateMar 21, 2018

Study points to potential misuse/abuse of ADHD drugs

A study published in the British Journal of Clinical Pharmacology suggests that methylphenidate, an ADHD medication, may be subject to misuse and/or abuse. The study found inconsistent patterns of use among adult users, particularly those aged 25-49 years.

SourceWiley·JournalBritish Journal of Clinical Pharmacology·DateMar 7, 2018

Weight loss surgery linked to an increased risk of inflammatory bowel disease

A new analysis found a link between weight loss surgery and an increased risk of inflammatory bowel disease (IBD), with patients having a nearly 2-times higher likelihood of developing IBD. The mechanism behind this association is unclear, but alterations in gut microbes and vitamin D/bile salt deficiencies may play a role.

SourceWiley·JournalAlimentary Pharmacology & Therapeutics·DateMar 7, 2018

Study finds racial differences in cure rates for Hepatitis C

A recent study published in Pharmacology Research & Perspectives reveals racial disparities in Hepatitis C cure rates among patients receiving optimal therapies. The findings show lower cure rates for African American individuals compared to White individuals, highlighting the need for further exploration of underlying causes.

SourceWiley·JournalPharmacology Research & Perspectives·DateFeb 22, 2018

Do pain medications carry different heart risks?

A Taiwanese database study of 55,629 patients with hypertension found no significant difference in cardiovascular risk between cyclooxygenase-2 enzyme selective NSAIDs and nonselective NSAIDs. Most commonly used NSAIDs have similar cardiovascular safety profiles under low-to-moderate daily doses and short-term treatment periods.

SourceWiley·JournalBritish Journal of Clinical Pharmacology·DateFeb 22, 2018

More work is needed to determine appropriate drug doses for children

A recent study analyzing pediatric drug dosage guidelines found inconsistencies in recommended doses, with varying results from allometric scaling and prior patterns of use. The analysis suggests a need for more precise treatment approaches to address the complexities of pediatric dosing.

SourceWiley·JournalBritish Journal of Clinical Pharmacology·DateFeb 7, 2018

Are women really under-represented in clinical trials?

A recent review of US Food and Drug Administration registration data reveals that the proportion of women participating in clinical trials gradually increases from phase 1 to phase 2/3 trials. The analysis of 38 drugs with over 185,000 trial participants shows no systemic significant under-representation of women.

SourceWiley·JournalBritish Journal of Clinical Pharmacology·DateJan 11, 2018

Could melatonin be the key to healthy aging?

Research suggests that melatonin treatments can improve sleep quality, physical health, and mental well-being in older adults. Melatonin deficiency is associated with decreased circadian system robustness and increased risks of age-related diseases.

SourceWiley·JournalBritish Journal of Pharmacology·DateJan 10, 2018

Ames Lab-led team maps magnetic fields of nano-objects in liquid

A research team led by Tanya Prozorov has demonstrated the first high-resolution mapping of magnetic fields in bacterial cells and magnetic nano-objects in liquid. This capability has vast potential for scientific breakthroughs in physics, nanotechnology, biofuels conversion, biomedical engineering, catalysis, batteries, and pharmacology.

SourceDOE/Ames National Laboratory·JournalJournal of The Royal Society Interface·DateDec 21, 2017

Diabetes, but not diabetes drug, linked to poor pregnancy outcomes

A study published in British Journal of Clinical Pharmacology found that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for major birth defects and pregnancy loss compared to the general population. The increased risk is not due to metformin, but rather the underlying diabetes.

SourceWiley·JournalBritish Journal of Clinical Pharmacology·DateDec 20, 2017

New pain treatment tested in humans

A new study published in the British Journal of Clinical Pharmacology demonstrates pain relief in humans using a Trk inhibitor. The study involved 20 participants and compared the inhibitor with pregabalin, ibuprofen, and placebo.

SourceWiley·JournalBritish Journal of Clinical Pharmacology·DateNov 27, 2017

Analysis provides reassurance on the safety of biosimilars

A recent study of publicly available regulatory documents found that biosimilars have a comparable safety profile to their originators. The analysis identified only minor differences in safety concerns for most substances, with the exception of infliximab, where more issues were reported.

SourceWiley·JournalBritish Journal of Clinical Pharmacology·DateNov 22, 2017

Study examines the effects of a marijuana alternative

Researchers investigated the effects of synthetic cannabinoid JWH-018, finding initial impairments in neurocognitive function and subjective feelings of high. The results suggest that common use scenarios may not be fully represented by the low drug concentrations used in the trial.

SourceWiley·JournalBritish Journal of Pharmacology·DateNov 22, 2017